National Bank of Canada
IHE icon

National Bank of Canada’s iShares US Pharmaceuticals ETF IHE Stock Holding History

National Bank of Canada’s Portfolio IHE Stock Details IHE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$22.6K Sell
261
-260
-50% -$22.8K ﹤0.01% 2150
2025
Q4 		$44.2K Sell
521
-64
-11% -$5.11K ﹤0.01% 1988
2025
Q3 		$42.4K Buy
585
+175
+43% +$12.1K ﹤0.01% 1976
2025
Q2 		$26.8K Hold
410
– – ﹤0.01% 2106
2025
Q1 		$28.9K Hold
410
– – ﹤0.01% 2003
2024
Q4 		$26.9K Sell
410
-28
-6% -$1.93K ﹤0.01% 2103
2024
Q3 		$30.9K Sell
438
-30
-6% -$2.09K ﹤0.01% 1833
2024
Q2 		$31K Hold
468
– – ﹤0.01% 1841
2024
Q1 		$30.5K Sell
468
-93
-17% -$6.15K ﹤0.01% 1911
2023
Q4 		$35K Buy
561
+411
+274% +$24.2K ﹤0.01% 1879
2023
Q3 		$8.71K Hold
150
– – ﹤0.01% 2224
2023
Q2 		$8.94K Sell
150
-45
-23% -$2.67K ﹤0.01% 2218
2023
Q1 		$11.4K Hold
195
– – ﹤0.01% 2102
2022
Q4 		$12.1K Sell
195
-27
-12% -$1.62K ﹤0.01% 2131
2022
Q3 		$12K Hold
222
– – ﹤0.01% 2136
2022
Q2 		$14K Hold
222
– – ﹤0.01% 2170
2022
Q1 		$14K Buy
222
+96
+76% +$6.08K ﹤0.01% 2275
2021
Q4 		$8K Buy
+126
New +$7.99K ﹤0.01% 2425

Other funds holding IHE

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $8.07B AUM 24.97% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ACA
Aptus Capital Advisors Fairhope, Alabama $12.7B AUM 17.41% 1-Year Est. Return
MSCM
McElhenny Sheffield Capital Management Dallas, Texas $404M AUM 19.8% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
ACM
Anfield Capital Management Irvine, California $363M AUM 24.08% 1-Year Est. Return
IWS
Insight Wealth Strategies San Ramon, California $1.02B AUM 38% 1-Year Est. Return

National Bank of Canada's IHE Position: Q1 2026 in Review

National Bank of Canada reduced its iShares US Pharmaceuticals ETF (IHE) stake by 50% in Q1 2026, selling an estimated $22.8K and leaving 261 shares worth $22.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2150.

National Bank of Canada first reported a position in IHE in Q4 2021 and has held it in 18 quarters since. The position peaked at $44.2K in Q4 2025. 194 funds tracked by Wall St. Rank hold IHE as of Q1 2026.

  • National Bank of Canada held 261 shares of iShares US Pharmaceuticals ETF worth $22.6K as of Q1 2026.
  • National Bank of Canada sold 260 iShares US Pharmaceuticals ETF shares in Q1 2026, an estimated $22.8K.
  • iShares US Pharmaceuticals ETF made up ﹤0.01% of National Bank of Canada's portfolio in Q1 2026, its #2150 holding.
  • National Bank of Canada first reported a position in iShares US Pharmaceuticals ETF in Q4 2021 and has held it in 18 quarters since.
  • National Bank of Canada's iShares US Pharmaceuticals ETF position peaked at $44.2K in Q4 2025.
  • 194 funds tracked by Wall St. Rank held iShares US Pharmaceuticals ETF as of Q1 2026.

Based on National Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.